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Recent work has suggested interleukin-18 to represent
a proinflammatory cytokine that contributes to sys-
temic and local inflammation. As the process of
cutaneous wound healing crucially involves an
inflammatory phase of repair, we investigated the
regulation of interleukin-18 during the repair pro-
cess. In non-wounded skin we observed high levels
of interleukin-18 mRNA, whereas corresponding
interleukin-18 protein was expressed only at low basal
levels. Upon injury, we found a rapid and large induc-
tion of interleukin-18 protein expression, which is
directly correlated with decreasing mRNA levels
within the wound. Immunohistochemical analysis
revealed different sites of expression in the wounded
area, with keratinocytes as one major source of
The process of cutaneous wound repair is characterizedby four overlapping phases involving hemostasis,inflammation, proliferation, and the remodeling phaseof repair. After injury, new tissue formation startswith re-epithelialization and is followed by granul-
ation tissue formation. The latter process encompasses macrophage
accumulation, fibroblast ingrowth, matrix deposition, and angio-
genesis (Clark, 1996). Inflammation, re-epithelialization, and
granulation tissue formation are driven in part by a complex
mixture of growth factors and cytokines, which are released
into the area of injury. Especially, proinflammatory cytokines are
important mediators of cellular actions during tissue regeneration.
Very recently, the group of proinflammatory cytokines is extended
by a new member, first described as interferon (IFN) -γ-inducing
factor (IGIF) (Nakamura et al, 1989). After purification of IGIF in
1995 (Okamura et al, 1995a), cDNA of murine and human IGIF
were cloned subsequently (Okamura et al, 1995b; Ushio et al,
1996). As recombinant IGIF exhibited pleiotropic immunologic
activities, the conventional name interleukin (IL)-18 was proposed.
The gene for IL-18 encodes a precursor polypeptide (pro-IL-
18), which is biologically inactive (Okamura et al, 1995b). IL-18
resembles structural similarity to the IL-1 family of proteins (Bazan
et al, 1996). Similar to IL-1β, pro-IL-18 is cleaved by IL-1β
converting enzyme at the authentic processing site to generate the
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interleukin-18 production. The counterregulation of
interleukin-18 mRNA and protein expression during
wound repair in vivo might represent a general
mechanism for interleukin-18 expressional regula-
tion, as cytokine-stimulated keratinocytes exhibit a
similar downregulation of interleukin-18 mRNA that
is directly associated with increasing interleukin-18
protein levels in vitro. The rapid induction of
interleukin-18 during wound healing suggests a role
for interleukin-18 within the early phase of repair
rather than a role in costimulation of interferon-g
release from T cells, which are present in high numbers
within the wounded area only during the late inflam-
matory phase of repair. Key words: cytokines/keratino-
cytes/skin. J Invest Dermatol 113:369–374, 1999
mature and active form of IL-18 (Ghayur et al, 1997; Gu et al,
1997). Target specificities and receptors of IL-18 and IL-1, however,
are different from each other.
Immune cell-derived IL-18 is described to possess two main
biologic functions. Primarily, IL-18 is a costimulant for T helper
cell 1 cytokine production by acting as a costimulant for IFN-γ
production with IL-12, IL-2, microbial agents, or mitogens (Kohno
et al, 1997; Robinson et al, 1997). Additionally, IL-18 is able to
directly induce tumor necrosis factor (TNF)-α, IL-1β, both CXC
and CC chemokines (Puren et al, 1998), and nuclear translocation
of nuclear factor-κB (Matsimoto et al, 1997; Robinson et al, 1997),
placing IL-18 among other proinflammatory cytokines as a most
likely contributor to systemic and local inflammation.
In this study, we have investigated the expression pattern of IL-
18 during the highly dynamic process of cutaneous wound repair.
We provide evidence for a counterregulatory mechanism of IL-18
mRNA and protein expression during the inflammatory phase of
repair. Furthermore, we describe a dramatic increase in IL-18
protein with highest levels early after injury. As T cell numbers
peak at day 7 in skin wounds (Fishel et al, 1987), our data suggest
that the initial role of IL-18 during the repair process is most likely
to be independent from its ability to trigger the release of T cell-
derived IFN-γ.
MATERIALS AND METHODS
Wounding and preparation of wounds To examine IL-18 expression
during the wound healing process, six full-thickness wounds were created
on the backs of female BALB/C mice (3 mo old). Mice were anesthetized
with a single intraperitoneal injection of ketamine (80 mg per kg body
weight)/Xylazin (10 mg per kg body weight). The hair on the back of
these mice was cut, and the back was subsequently wiped with 70%
ethanol. Six full-thickness wounds (5 mm in diameter, 3–4 mm apart)
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were made on the backs of these mice by excising the skin and the
underlying panniculus carnosus. The wounds were allowed to form a scab.
Skin biopsy specimens from four animals were obtained 1, 3, 5, 7, and
13 d after injury. An area of 7–8 mm in diameter which included the scab
and the complete epithelial margins was excised at each time point. As a
control, a similar amount of skin was taken from the backs of four non-
wounded mice. In every experiment, the wounds from four animals (16
wounds) and the non-wounded back skin from four animals, respectively,
were combined, frozen immediately in liquid nitrogen, and stored at
–80°C until used for RNA or protein isolation. All animal experiments
were carried out according to the guidelines and with the permission from
the local government of Hessen.
Histology Mice were wounded as described above. Animals were killed
at day 5 after injury. Complete wounds were isolated from the middle of
the back, bisected, and frozen in tissue freezing medium. Six micrometer
sections from the middle of the wound were stained with hematoxylin
and eosin.
Immunohistochemistry Mice were wounded as described above.
Animals were killed at days 1, 3, and 13 after injury. Complete wounds
were isolated from the middle of the back, bisected, and frozen in tissue
freezing medium. Six micrometer frozen sections were fixed with acetone
and treated for 10 min at room temperature with 1% H2O2 in phosphate-
buffered saline to inactivate endogenous peroxidases. They were sub-
sequently incubated for 60 min at room temperature with a polyclonal
anti-serum against human IL-18 (PeproTech, Frankfurt, Germany) (1:100
diluted in phosphate-buffered saline, 0.1% goat serum albumin). The slides
were subsequently stained with the avidin–biotin–peroxidase complex
system from SantaCruz (Heidelberg, Germany) using 3-amino-9-ethyl-
carbazole as a chromogenic substrate. After development, they were
rinsed with water, counterstained with hematoxylin (Sigma, Deisenhofen,
Germany), and mounted.
Preparation of tissue and cell culture lysates and western blot
analysis Skin samples and keratinocytes from the cell culture experiments
were homogenized in lysis buffer (1% Triton X-100, 20 mM Tris/HCl,
pH 8.0, 137 mM NaCl, 10% glycerol, 5 mM ethylenediamine tetraacetic
acid, 1 mM phenylmethylsulfonyl fluoride, 1% aprotinin, 15 µg leupeptin
per ml). The tissue extract was cleared by centrifugation. Fifty micrograms
of total protein from these lysates was separated using sodium dodecyl
sulfate–gel electrophoresis. After transfer to a polyvinylidene fluoride
membrane, IL-18 protein was detected using a monoclonal antibody raised
against human IL-18 (Kalina et al, 1998). A secondary antibody coupled
to horseradish peroxidase and the enhanced chemiluminescence detection
system were used to visualize IL-18 protein. Phenylmethylsulfonyl fluoride,
aprotinin, and leupeptin were from Sigma and the enhanced chemilumines-
cence detection system was obtained from Amersham (Freiburg, Germany).
RNA isolation and RNase protection assay RNA isolation was
performed as described (Chomczynski and Sacchi, 1987). Thirty micrograms
of total RNA from wounded or non-wounded skin were used for RNase
protection assays. RNase protection assays were carried out as described
(Werner et al, 1992). Protected fragments were separated on 5% acrylamide/
8 M urea gels and analyzed using a PhosphoImager (Fuji, Straubenhardt,
Germany).
Cell culture The human keratinocyte cell line HaCaT (Boukamp et al,
1988) was cultured in Dulbecco’s modified Eagle’s medium with 10% fetal
bovine serum. For the induction experiments, cells were grown to
confluency without changing the medium and rendered quiescent by a
24 h incubation in Dulbecco’s modified Eagle’s medium without serum.
Cells were then incubated for varying time periods in fresh Dulbecco’s
modified Eagle’s medium containing a combination of proinflammatory
cytokines (2 nM IL-1β, 2 nM TNF-α, and 100 U IFN-γ per ml). Aliquots
of cells were harvested before and at different time points after treatment
and used for RNA and protein isolation.
Probe cDNA The murine and human IL-18 cDNA probes, and the
cDNA probe for murine vascular endothelial growth factor, respectively,
were cloned by polymerase chain reaction. The cloned cDNA fragments
correspond to nucleotides 318–605 (for murine IL-18), nucleotides 335–
627 (for human IL-18), and nucleotides 139–455 (for murine vascular
endothelial growth factor) of the published sequences (Breier et al, 1992;
Okamura et al, 1995b; Ushio et al, 1996).
Statistical analysis Data are shown as mean 6 SD. The data are
presented either as x-fold induction or as percentage change compared
with the control (100%). For each reagent, in each set of conditions, data
were analyzed by Student’s t test using the software SigmaPlot (Jandel
Scientific, Erkrath, Germany).
RESULTS
Counterregulation of IL-18 mRNA and protein expression
during wound repair To determine a possible role for IL-18
in cutaneous wound repair, we first investigated the time course
of IL-18 mRNA and protein expression during this process. We
isolated total RNA and total protein from full-thickness excisional
wounds at different intervals after injury and performed RNase
protection assays, or western blot analysis, respectively. Sixteen
wounds (for RNA) and four wounds (for protein) from the backs
of four mice were excised for each time point, combined and used
for RNA, or protein isolation. Normal skin from the back of non-
wounded mice was used as a control. The area of injured tissue
which has been removed from the animals for the isolation of
RNA and protein is shown in Fig 3(A). Exactly one-half of a 5 d
wound is shown in Fig 3(A), and the site where the tissue was cut
is marked by arrows indicating that the wound margins have been
included within the area of wound tissue which has been removed
for analysis. As shown in Fig 1 (ctrl), IL-18 was highly expressed
at the mRNA level in normal back skin. Notably, these observed
high basal levels of IL-18 mRNA did not subsequently result in
high IL-18 protein levels in unwounded controls (Fig 2A, ctrl), as
we could detect only low levels of IL-18 protein in normal skin.
Upon injury, a strong and rapid decrease of IL-18 mRNA levels
was observed within 24 h after wounding, reaching reduced
minimum levels (40–50% of control) between days 1 and 3 after
injury. The late inflammatory phase of repair (days 5–7 after injury)
is characterized by re-increasing levels of IL-18 mRNA, as, within
the wounded area, cellular pools of IL-18 mRNA started to fill up
again. At day 13 after injury, all wounds were completely re-
epithelialized, but the granulation tissue still revealed a high
cellularity (Fig 3F). At this stage of the repair process, expression
of IL-18 mRNA again reached the high basal levels detected in
unwounded skin.
As a next step, we examined whether the observed decrease of
IL-18 mRNA expression after skin injury correlates with decreased
levels of immunoreactive IL-18 protein in wounds. For this purpose,
lysates of non-wounded skin and from 1, 3, 5, 7, and 13 d wounds
were analyzed by western blotting for the presence of IL-18 protein
(Fig 2). Protein lysates of human myelomonocytic KG-1 cells,
which are known to produce IL-18 protein (Konishi et al, 1997),
and human skin, respectively, are used as a positive control for a
functional antibody. As mentioned above, we detected a differential
regulation of IL-18 mRNA and protein in non-wounded control
skin, as high IL-18 mRNA did not correlate with the low amounts
of IL-18 protein expressed in normal skin (Figs 1 and 2). Upon
injury, we were surprised to observe a dramatic counterregulation
of IL-18 protein expression compared with IL-18 mRNA levels.
In contrast to decreased mRNA levels, IL-18 protein levels were
high in the lysates obtained from 1, 3, 5, and 7 d wounds (Fig 2).
The strong increase (about 4-fold) in IL-18 protein was maximal
at day 1, representing the time point of tissue repair when IL-18
mRNA had declined to a minimum (Fig 1). It is remarkable that
rising levels of IL-18 mRNA, starting to increase again at day 5
postwounding, are directly correlated with a reduction of IL-18
protein during the remaining process of repair. Thirteen days after
injury, when wounds are completely re-epithelialized, the observed
counterregulation finally leads to the expressional state of
unwounded skin: high IL-18 mRNA levels are associated with
low IL-18 protein levels. Remarkably, a second band which is
recognized by the monoclonal anti-IL-18 antibody (Fig 2A, right
panels) fits the expected size (22 kDa) of unprocessed pro-IL-18.
Thus, IL-18 protein which could be detected during the early and
late inflammatory phase of wound repair, and during granulation
tissue formation and re-epithelialization (Fig 2) is most likely to
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Figure 1. IL-18 mRNA is transiently decreased during wound
healing. (A) Total cellular RNA (20 µg) from normal and wounded back
skin was analyzed by RNase protection assay for expression of IL-18. The
regulation of IL-18 mRNA expression in mice of two independent series
(indicated as I and II) is shown. Sixteen wounds (n 5 16) from the backs
of four animals were excised for each experimental time point and used
for RNA isolation. The time after injury is indicated at the top of each
lane. Control skin refers to non-wounded skin of normal mice. One
thousand counts per minute of the hybridization probe were added to the
lane labeled probe. The degree of IL-18 mRNA reduction assessed by
PhosphoImager (Fuji) analysis of the radiolabeled gels is shown schematically
in (B). Expression of GAPDH mRNA is shown as a loading control for
both experiments. Upregulation of vascular endothelial growth factor
mRNA expression is shown as positive control using the same set of total
RNA from series I (A, lower panel).
represent the biologically active, mature protein (18.3 kDa), as the
result of an highly effective processing of pro-IL-18.
Expression of IL-18 protein in 1, 3, and 13 d mouse wound
tissue To investigate the localization of IL-18 in unwounded
skin and during wound healing, sections from normal back skin
and 1, 3, and 13 d full-thickness mouse wounds were stained with
a monospecific, polyclonal antibody against IL-18 protein. The
observed constitutive, but low level basal expression of IL-18
protein in unwounded skin (Fig 2) was due to expression in the
epidermis and hair follicles, whereas the underlying dermal cells
did not express IL-18 protein (Fig 3B). At early time points after
wounding (1 and 3 d), IL-18 was expressed at high levels (Fig 2).
The late 13 d time point was chosen to determine the cell types
which are responsible for the remaining low-level expression of
IL-18 protein after re-epithelialization. In 1 d wounds, a remarkably
strong expression of IL-18 was seen in a population of cells
infiltrating the wounded area, thereby forming invading ‘‘groups’’
of strongly labeled cells and a population of labeled cells localized
Figure 2. Large induction of IL-18 protein expression during wound
repair. (A) Total protein (50 µg) from lysates of non wounded and
wounded back skin (days 1, 3, 5, 7, and 13 after injury, indicated at the
top of each lane) were analyzed by immunoblotting for the presence of
IL-18 protein. Four wounds (n 5 4) from the backs of four animals were
excised for each experimental time point and used for protein isolation.
IL-18 protein is indicated by an arrow. Staining of the PVDF membrane
after immunostaining using Ponceau S (Serva, Heidelberg, Germany) was
used as a loading control (lower panels). Total protein (50 µg) from lysates
of human myelomonocytic KG-1 cells and human skin, respectively, were
analyzed for IL-18 protein as a positive control (right panels). The degree
of IL-18 protein induction assessed by scanning densitometry (Molecular
Analyst, BioRad, Munich, Germany) is shown schematically in (B). Data
are expressed as mean 6 SD and presented as percentage induction
compared with the control (100%). *p , 0.05; **p , 0.01.
directly beneath the freshly formed blot clot (Fig 3C). These cells
are most likely to represent polymorphonuclear neutrophils, which
are the first cells invading the injured tissue. During the repair
process, however, localization of IL-18 expression changed, as the
protein could be detected in the granulation tissue and in the
epidermis in 3 d wounds (Fig 3D, E, indicated by arrows).
With the antibody, immunopositive signals were obtained in
keratinocytes, particularly within the hyperproliferative epithelium
at the wound edge (Fig 3D). Furthermore, strong signals were
detected in cells invading towards the granulation tissue. Owing
to cell shape, these strongly labeled cells seem to represent migrating
fibroblasts and infiltrating mononuclear immune cells, and therefore,
most likely macrophages (Fig 3E). Finally, we determined the
epidermis of the re-epithelialized wounds to be the source of the
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Figure 3. Expression of IL-18 protein in
unwounded skin and 1, 3, and 13 d mouse
wounds. (A) frozen serial section from a 5 d wound
stained with eosin and hematoxylin. The site from
which the wounded tissue was removed for RNA
and protein analysis from the back of the animals is
marked by arrows, indicating the amount of
unwounded tissue that is enclosed in the RNA and
protein assays. (B–F) Frozen serial sections from
unwounded skin, 1, 3, and 13 d mouse wounds were
incubated with a monospecific, polyclonal antibody
directed against human IL-18 and stained with the
avidin–biotin–peroxidase complex system using 3-
amino-9-ethylcarbazole as a chromogenic substrate.
Nuclei were counterstained with hematoxylin.
Unwounded skin is shown in (B), the 1 d wound is
shown in (C), the 3 d wound in (D, E), and the 13 d
wound in (F), respectively. Scale bars are 200 µm for
A, 100 µm for C and F, 50 µm for E, and 30 µm
for B and D, respectively. Strongly immunopositive
signals within the sections are indicated with arrows.
e, epidermis; g, granulation tissue, h, hair follicle; he,
hyperproliferative epithelium; m, muscle layer, s, scab.
remaining low-level expression of IL-18 protein, as the underlying
granulation tissue revealed nearly no labeled cells (Fig 3F). Owing
to the particularly strong labeling of the observed immunopositive
cell types within the wound, the anti-IL-18-antibody was most
likely to stain IL-18-synthesizing cells rather than receptor-bound
IL-18 protein, for which we would expect a much weaker and
peripheral staining of immunopositive cells.
Counterregulation of IL-18 gene expression by proinflam-
matory cytokines in cultured keratinocytes (HaCaT) We
used a cell culture approach to strengthen further the novel
counterregulatory mechanism for IL-18 mRNA and protein expres-
sion observed during the wound healing process in vivo. As
keratinocytes turned out to be one of the main sources of IL-18
expression during wound repair, we have chosen the human
keratinocyte cell line HaCaT (Boukamp et al, 1988) to induce IL-
18 expression. As the infiltration of polymorphonuclear leukocytes
followed by macrophages is a crucial event in wound repair, we
tested the ability of cytokines produced by these cells to alter IL-
18 mRNA and protein levels in keratinocytes. As shown in Fig 4,
we could confirm the counterregulatory mechanism observed for
IL-18 expression in vivo, as keratinocytes in vitro respond to a
cytokine-mix (TNF-α, IL-1β, IFN-γ) in a similar manner. The
keratinocytes potently responded to the cytokine stimulus, as the
high basal levels of IL-18 mRNA observed in untreated cells were
dramatically reduced within 12 h after stimulation. At this time
point, IL-18 mRNA was reduced to a minimum (5% of control)
and only hardly detectable (Fig 4A). Similar to the in vivo situation,
IL-18 mRNA levels re-increased and mRNA expression levels
were high again in keratinocytes after 32 h of cytokine treatment.
We could observe a large increase in IL-18 protein expression
(Fig 4B) during that time period after cytokine stimulation, which
is characterized by a strong decrease in IL-18 mRNA (Fig 4A).
Therefore, these data clearly support the counterregulation of IL-
18 mRNA and protein expression which could be observed in the
wound healing experiments.
DISCUSSION
The wound healing process, initiated upon injury to overcome
tissue damage, represents a highly dynamic process. This repair
process requires the coordination between involved tissues and cell
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Figure 4. Counterregulation of IL-18 mRNA and
protein expression by inflammatory cytokines in
cultured keratinocytes (HaCaT). Keratinocytes
were rendered quiescent by serum starvation. Cells
were simultaneously stimulated with IL-1β and TNF-α
(2 nM), and IFN-γ (100 U per ml) for 3, 8, 12, 16,
24, or 32 h as indicated. (A) Total cellular RNA (20 µg)
from these cells were analyzed by RNase protection
assay for IL-18 mRNA expression. One thousand
counts per minute of the hybridization probe were used
as a size marker. The degree of IL-18 mRNA reduction
as assessed by PhosphoImager (Fuji) analysis of the
radiolabeled gels is shown schematically in the right
panel. Data from three independent cell culture
experiments are expressed as mean 6 SD and presented
as percentage change compared with the control (100%).
**p , 0.01; ##p , 0.01 compared with time points
8, 12, and 16 h. Expression of GAPDH mRNA is
shown as a loading control. (B) Total protein (50 µg)
from lysates of these cells were analyzed by
immunoblotting for the presence of IL-18 protein.
IL-18 protein with an expected size of approximately
20 kDa was detected in stimulated cells and indicated
by an arrow.
lineages at the molecular and cellular level. Proliferation, migration,
matrix synthesis, contraction of the wound, and the presence of
signaling molecules within the wound site are crucial events for
the ongoing repair process that have to be closely regulated to
sustain a healing process that finally leads to an at least partial
reconstruction of the tissue. Proinflammatory cytokines and various
peptide growth factors are known to be key players in this process
(Moulin, 1995; Martin, 1997). First described as IGIF (Nakamura
et al, 1989), a novel cytokine has been identified and cloned: IL-
18 (Okamura et al, 1995b; Ushio et al, 1996). Recent studies
revealed two main functions for IL-18. Whereas, on one hand, IL-
18 acts as a costimulant for the production of IFN-γ and other
cytokines in T helper type 1 cells, on the other hand, IL-18 could
be placed among the other known proinflammatory cytokines due
to its ability to induce TNF-α, IL-1β, CC chemokine, and CXC
chemokine in monocytic cells (Dinarello et al, 1998; Puren et al,
1998; Yoshimoto et al, 1998). For these reasons we postulated that
this recently described cytokine might serve a role during the
inflammatory phase of cutaneous wound repair. There is, however,
no information available yet dealing with a possible role of IL-18
in processes of tissue regeneration. For unwounded skin, the
situation of IL-18 expression is characterized by high intracellular
pools of IL-18 mRNA that are not subsequently translated into
the corresponding protein, as IL-18 protein was only detectable at
low basal levels in lysates of normal skin. Using a model of
excisional wound repair in mice, we observed a strong increase in
IL-18 protein expression early upon injury. IL-18 protein levels
were highest at day 1, remained elevated until day 5, and sub-
sequently declined when re-epithelialization and granulation tissue
formation occurs. It is remarkable that increasing amounts of IL-
18 within the wound are associated with decreased IL-18 mRNA
pools. This finding suggests a very potent regulatory mechanism
for IL-18 expression after tissue injury: IL-18 becomes available
early after injury, as a transcriptional activation of producer cells is
not necessary. High levels of IL-18 mRNA are subsequently
translated and IL-18 protein secreted into the wound. Our data
suggest that, in part, IL-18 mRNA transcripts seem to be degraded,
as IL-18 protein synthesis moves on. This might reflect a regulatory
mechanism to avoid an overshooting IL-18 synthesis from the high
pools of mRNA. In line with the rapid induction of IL-18 after
injury, the precursor molecule of IL-18 was only hardly detectable:
pro-IL-18, which is biologically inactive and has to be cleaved by
the IL-1β converting enzyme to generate the mature active form
of IL-18 (Ghayur et al, 1997; Gu et al, 1997). Thus, cleavage of
pro-IL-18 by IL-1β converting enzyme is likely to be highly
efficient during repair. The observation that IL-18 release is
regulated via a post-transcriptional mechanism from high intracellu-
lar pools of IL-18 mRNA is further strengthened by cell culture
experiments using a keratinocyte cell line (HaCaT). This mechanism
seems to be a very potent alternative to another mechanism
described for IL-1β and keratinocyte growth factor-2 to circumvent
a transcriptional lag-phase after injury: IL-1β and keratinocyte
growth factor-2 are stored in large amounts in intact skin and
released postwounding (Raines et al, 1989; Nicosia et al, 1993;
Beer et al, 1997).
The cell types known until now to express IL-18 are hetero-
geneous, indicating that the potency to produce IL-18 is not
restricted to immune cells. Besides macrophages, IL-18 is reported
to be expressed in keratinocytes after contact with an allergen (Stoll
et al, 1997), in cells of the adrenal gland and the neurohypophysis
(Conti et al, 1997), in intestinal epithelial cells (Takeuchi et al,
1997), and osteoblasts (Udagawa et al, 1997). Therefore, we
could confirm previous reports, as keratinocytes and macrophages
exhibited a particularly strong IL-18-positive staining within the
wound. Immunohistochemistry further revealed most likely
infiltrating polymorphonuclear neutrophils (day 1) as producers of
IL-18. This is in line with a recent report which clearly identifies
this cell type as a potent source of cytokines of the IL-1 family
(Hu¨bner et al, 1996). In addition, our immunohistochemistry data
suggest migrating fibroblasts (day 3) to produce large amounts of
IL-18 as well. Staining of IL-18-positive fibroblasts is in agreement
with detection of IL-18 mRNA and protein in the dermis of
normal murine skin (Xu et al, 1998).
Unexpectedly, we observed highest amounts of IL-18 during
repair, when T cells have not yet infiltrated the injured area. T
lymphocyte numbers peak at day 7 of repair (Ross and Benditt,
1962; Fishel et al, 1987). Thus, the slightly elevated levels of IL-
18 observed at this stage of the healing process might contribute
to T helper type 1-derived IFN-γ and cytokine release during the
late inflammatory phase of repair. It is consistent with this finding
to suggest a restriction of the IFN-γ-inducing properties of IL-18
to the late inflammatory phase, as T cells which require the IL-18
costimulus to produce IFN-γ are not present in early wounds (Ross
and Benditt, 1962; Fishel et al, 1987). The observation, that IL-18
cannot act as IFN-γ inducing factor due to the absence of T cells
in early wounds corresponds to the well characterized deleterious
effects of IFN-γ for the healing process: IFN-γ inhibits keratinocyte
proliferation, decreases connective tissue formation, increases de-
position of mucopolysaccharides, inhibits neovascularization, and
finally leads to a delayed skin closure (Hancock et al, 1988; Granstein
et al, 1989, 1990; Miles et al, 1994). For these reasons, the
proinflammatory properties of IL-18 have to be discussed to be
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important for the regulation of early wound repair. IL-18 is reported
to induce directly TNF-α, IL-1β, the CXC chemokine IL-8, and
the CC chemokines macrophage-inflammatory protein-1α and
macrophage chemoattractant protein-1 in peripheral blood mono-
nuclear cells, and, thus, act as proinflammatory cytokine (Puren
et al, 1998). Therefore, by inducing the release of neutrophil and
monocyte chemoattractant proteins, we suggest a part for early
induced IL-18 to be involved in the amplification of signals guiding
increasing numbers of immune cells into the wound at the onset
of wound repair (Kunstfeld et al, 1998).
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